These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 34271109)

  • 1. Placebo-controlled trials with COVID-19 vaccines: participants first.
    Dal-Ré R
    J Clin Epidemiol; 2021 Oct; 138():211-212. PubMed ID: 34271109
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    Joffe S
    JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccine trials: The potential for "hybrid" analyses.
    Fleming TR; Nason M; Krause PR; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Aug; 18(4):391-397. PubMed ID: 34041932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo control group in COVID-19 vaccine trials: context and timing matters.
    Dal-Ré R
    Eur J Clin Pharmacol; 2022 Mar; 78(3):523-526. PubMed ID: 34837495
    [No Abstract]   [Full Text] [Related]  

  • 7. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 8. How do nocebo effects in placebo groups of randomized controlled trials provide a possible explicative framework for the COVID-19 pandemic?
    Amanzio M; Cipriani GE; Bartoli M
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):439-444. PubMed ID: 33682603
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
    Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Sisa I; Noblecilla E; Orozco F
    Lancet; 2021 Mar; 397(10277):878. PubMed ID: 33617776
    [No Abstract]   [Full Text] [Related]  

  • 12. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Dal-Ré R
    Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID: treatment trials are still urgent.
    Rauchman S
    Nature; 2021 Jun; 594(7861):26. PubMed ID: 34075245
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial participants' rights after authorisation of COVID-19 vaccines.
    Dal-Ré R; Orenstein W; Caplan AL
    Lancet Respir Med; 2021 Apr; 9(4):e30-e31. PubMed ID: 33476582
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing vaccines in the time of Covid: The changing landscape.
    Cash RA
    Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights.
    Srinivasan S
    Indian J Med Ethics; 2021; VI(2):1-6. PubMed ID: 33908351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces.
    Perosa F; Favoino E; Prete M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):567-568. PubMed ID: 33290205
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.